Technology Development Core
Technology Development Core
批准号:
10251185
负责人:
Wilbur A Lam
金额:
$75.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-18 至 2023-05-31
关键词:
AddressAdoptionCardiacClinicalCollaborationsCountryElectronicsEngineeringEvaluationFacultyFeedbackGoalsHematologyInstitutesLaboratoriesLinkLungMissionNanotechnologyNational Heart, Lung, and Blood InstitutePoint of Care TechnologyResearch PersonnelResourcesSleepSourceTechnologyTrainingTranslationsTweensUniversitiesValidationbaseclinical translationexperiencemicrosystemsnanofabricationtechnology developmentvalidation studies
中文摘要
核心2:技术开发/改进核心项目摘要
亚特兰大微系统工程中心的技术开发/改进核心
CARE Technology(ACME POCT)将作为以下项目的技术改进实验室
在中心。ACME POCT的目标是帮助和支持来自全国各地的发明家
开发基于概念验证微系统的POC技术,用于心脏、肺、血液和
睡眠应用程序,以定义其临床需求、进行临床验证并改进其技术,
加速翻译和临床采用的道路并直接解决那里的障碍的目标-
的。技术开发/改进核心将提供必要的人员以及工程重新
佐治亚理工学院电子和纳米技术研究所(IEN)的消息来源。密切合作是--
Tweet Ien和埃默里大学的临床专业知识,以及来自验证和
来自临床翻译和验证核心的用户体验研究将确保临床动机的技术-
本体学提炼。技术开发/改进核心的使命是促进成功的
在NHLBI领域改进基于微系统的POC技术,以提供到工程实践的链接
PERTS,支持技术改进所需的工具包,并为技术培训提供资源-
对研究人员和调查人员的调查。
英文摘要
Core 2: Technology Development/Refinement Core Project Summary
The Technology Development/Refinement Core of the Atlanta Center for Microsystems Engineered Point-of-
Care Technology (ACME POCT) will serve as the technology refinement laboratory for projects supported by
the center. The goal of ACME POCT is to assist and enable inventors from across the country who have de-
veloped proof-of-concept microsystems-based POC technologies for cardiac, pulmonary, hematologic and
sleep applications to define their clinical needs, conduct clinical validation, and refine their technology, with the
objective of accelerating the path to translation and clinical adoption and directly addressing the barriers there-
of. The Technology Development/Refinement Core will provide necessary staff as well as engineering re-
sources within Georgia Tech's Institute for Electronics and Nanotechnology (IEN). The close collaboration be-
tween IEN and the clinical expertise at Emory University, as well as the direct feedback from validation and
user experience studies from the Clinical Translation and Validation Core, will insure clinically-motivated tech-
nology refinement. The mission of the Technology Development/Refinement Core is to facilitate the successful
refinement of microsystem-based POC technologies in the NHLBI domain, to provide links to engineering ex-
perts, to support the toolset necessary for technology refinement, and to provide resources for technical train-
ing of researchers and investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10265612
-
项目类别:
-
资助金额:$708.5万
-
财政年份:2020
-
负责人:Wilbur A Lam
-
依托单位:
Engineering biophysical microtechnologies for hematologic applications in health and disease
-
批准号:10579951
-
项目类别:
-
资助金额:$78.45万
-
财政年份:2019
-
负责人:Wilbur A Lam
-
依托单位:
Engineering biophysical microtechnologies for hematologic applications in health and disease
-
批准号:10350610
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2019
-
负责人:Wilbur A Lam
-
依托单位:
Engineering biophysical microtechnologies for hematologic applications in health and disease
-
批准号:9898450
-
项目类别:
-
资助金额:$75.73万
-
财政年份:2019
-
负责人:Wilbur A Lam
-
依托单位:
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.
-
批准号:10458078
-
项目类别:
-
资助金额:$69.89万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Emergency COVID-19 Variant Supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
-
批准号:10476947
-
项目类别:
-
资助金额:$1548.19万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
-
批准号:10715493
-
项目类别:
-
资助金额:$161.84万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.
-
批准号:10325763
-
项目类别:
-
资助金额:$71.95万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Administrative Core
-
批准号:10715494
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies
-
批准号:10022309
-
项目类别:
-
资助金额:$73.7万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
-
批准号:10488287
-
项目类别:
-
资助金额:$137.27万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Administrative Core
-
批准号:10488288
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Technology Development Core
-
批准号:10001344
-
项目类别:
-
资助金额:$75.36万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Administrative Core
-
批准号:10001332
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Administrative Core
-
批准号:10251184
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Technology Development Core
-
批准号:10488290
-
项目类别:
-
资助金额:$76.89万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Technology Core
-
批准号:10715495
-
项目类别:
-
资助金额:$97.31万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
ACME POCT EMERGENCY COVID-19 VARIANT TESTING & INDEPENDENT TEST ASSESSMENT EVALUATION SUPPLEMENT
-
批准号:10652790
-
项目类别:
-
资助金额:$1586.47万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies
-
批准号:10247064
-
项目类别:
-
资助金额:$71.98万
-
财政年份:2018
-
负责人:Wilbur A Lam
-
依托单位:
Endothelialized microfluidics for sickle cell disease research & drug discovery
-
批准号:8614121
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2014
-
负责人:Wilbur A Lam
-
依托单位:
海外基金